SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000816284-19-000020
Filing Date
2019-03-01
Accepted
2019-03-01 16:03:18
Documents
11
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A celgenecorp10-ka.htm 10-K/A 1797791
2 EXHIBIT 31.3 exhibit313.htm EX-31.3 5827
3 EXHIBIT 31.4 exhibit314.htm EX-31.4 6133
4 EXHIBIT 99.1 exhibit991.htm EX-99.1 93274
5 chart-06c4fd51a53310efa9ba03.jpg GRAPHIC 22809
6 chart-5571d98cc937e32c411a03.jpg GRAPHIC 21114
7 chart-7500d0f41b74944d9b0a03.jpg GRAPHIC 59832
8 partiiiv12820191image2.gif GRAPHIC 9130
9 partiiiv12820191image3.gif GRAPHIC 7611
10 partiiiv12820191image4.gif GRAPHIC 4273
11 partiiiv12820191image5.gif GRAPHIC 6858
  Complete submission text file 0000816284-19-000020.txt   2086269
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34912 | Film No.: 19649201
SIC: 2834 Pharmaceutical Preparations